Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care
NEW YORK -- August 29, 2013
Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Morgan Stanley
Global Health Care Conference on Monday, September 9, 2013, in New York.
Charles Bancroft, executive vice president & chief financial officer, and
Francis Cuss, executive vice president & chief scientific officer, will
participate in a question and answer session about the company at 10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of
the session at http://investor.bms.com. An archived edition of the session
will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.
Laura Hortas, 609-252-4587, firstname.lastname@example.org
Ranya Dajani, 609-252-5330, email@example.com
Ryan Asay, 609-252-5020, firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.